'Like a sieve': An exploratory study on cognitive impairments in patients with multiple myeloma

European Journal of Cancer Care

Volumn 19, Issue 6, 2010, Pages 721-728

  Potrata, B ^a   Cavet, J ^b   Blair, S ^b   Howe, T ^b   Molassiotis, A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Cognitive impairment; Lack of concentration; Memory loss; Multiple myeloma; Stem cell transplantation

Indexed keywords

ADAPTIVE BEHAVIOR; ADULT; AGED; ARTICLE; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; QUESTIONNAIRE; RECALL; RETROSPECTIVE STUDY; SHORT TERM MEMORY;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MENTAL RECALL; MIDDLE AGED; MULTIPLE MYELOMA; NEUROPSYCHOLOGICAL TESTS; QUALITATIVE RESEARCH; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 79955656268     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2009.01145.x     Document Type: Article

References (42)

1. Acevedo A. & Loewenstein D. (2007) Nonpharmacological cognitive interventions in aging and dementia. Journal of Geriatric Psychiatry and Neurology 20, 239-249.
2. Bataille R. & Harousseau J. (1997) Multiple myeloma. New England Journal of Medicine 336, 1657-1664.
3. Beglinger L., Duff K., Van Der Heiden S., Moser D.J., Bayless J.D., Paulsen J.S. & Gingrich R. (2007) Neuropsychological and psychiatric functioning pre- and posthematopoietic stem cell transplantation in adult cancer patients: a preliminary study. Journal of the International Neuropsychological Society 13, 172-177.
4. Birgegård G., Gascón P. & Ludwig H. (2006) Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European Cancer Anaemia Survey. European Journal of Haematology 77, 378-386.
5. Byrne T. (2005) Cognitive sequelae of brain tumor treatment. Current Opinion in Oncology 18, 662-666.
6. Charmaz K. (2000) Grounded theory: objectivist and constructivist methods. In: Handbook of Qualitative Research (eds Denzin N. & Lincoln Y.), pp. 509-535. Sage, Thousand Oaks, CA, USA.
7. Christo P., Grabow T. & Raja S. (2004) Opioid effectiveness, addiction, and depression in chronic pain. Advances in Psychosomatic Medicine 25, 123-137.
8. Cleeland C.S., Mendoza T.R., Wang X.S., Chou C., Harle M.T., Morrissey M. & Engstrom M.C. (2000) Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 89, 1634-1646.
9. Dvorak C. (2006) Common complaints, difficult diagnosis: multiple myeloma. Journal of the American Academy of Nurse Practitioners 18, 190-194.
10. Ersek M., Cherrier M., Overman S. & Irving G. (2004) The cognitive effects of opioids. Pain Management Nursing 5, 75-93.
11. Ferguson R.A., Ahles T.A., Saykin A.J., McDonald B.C., Furstenberg C.T., Cole B.F. & Mott L.A. (2006) Cognitive-behavioral management of chemotherapy-related cognitive change. Psycho-oncology 16, 772-777.
12. Fox S., Mitchell S. & Booth-Jones M. (2006) Cognitive impairment in patients with brain tumors: assessment and intervention in the clinic setting. Clinical Journal of Oncology Nursing 10, 169-176.
13. Greenlee R., Murray T., Bolden S. & Wingo P. (2000) Cancer statistics 2000. Cancer Journal of Clinicians 50, 7-33.
14. Gridelli C., Langer C., Maione P., Rossi A. & Schild S. (2007) Lung cancer in the elderly. Journal of Clinical Oncology 25, 1898-1907.
15. Grover J., Uppal G. & Raina V. (2002) The adverse effects of thalidomide in relapsed and refractory patients of multiple myeloma. Annals of Oncology 13, 1636-1640.
16. Hayden P.J., Keogh F., Ni Conghaile M., Carroll M., Crowley M., Fitzsimon N., Gardiner N., Vandenberghe E., O'Riordan J. & McCann S.R. (2004) A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase. Bone Marrow Transplantation 34, 545-556.
17. Hensley M.L., Correa D.D., Thaler H., Wilton A., Venkatraman E., Sabbatini P., Chi D.S., Dupont J., Spriggs D. & Aghajanian C. (2006) Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning. Gynecologic Oncology 102, 270-277.
18. Hodson R. & Keady J. (2008) Mild cognitive impairment: a review and nursing implications. British Journal of Nursing 17, 368-373.
19. Hurria A. & Lachs M. (2007) Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer? Breast Cancer Research and Treatment 103, 259-268.
20. Jansen C., Miaskowski C., Dodd M. & Dowling G. (2007) A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncology Nursing Forum 34, 997-1005.
21. Joly F., Alibhai S., Galica J., Park A., Yi Q. & Wagner L. (2006) Impact of antrogen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. Journal of Urology 176, 2443-2447.
22. Kiss T., Abdolell M., Jamal N., Minden M., Lipton J. & Messner H. (2002) Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. Journal of Clinical Oncology 20, 2334-2343.
23. Klein M., Reijneveld J. & Heimans J. (2008) Subjective ratings vs. objective measurement of cognitive function: in regard to van Beek etal. International Journal of Radiation Oncology, Biology, Physics 70, 961-962.
24. Lawlor P. (2002) The panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisal. Cancer 94, 1836-1853.
25. Lichtman S. (2006) Therapy insight: therapeutic challenges in the treatment of elderly cancer patients. Nature Clinical Practice. Oncology 3, 86-93.
26. Matsuda T., Takayama T., Tashiro M., Nakamura Y., Ohashi Y. & Shimozuma K. (2005) Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients - evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer 12, 279-287.
27. Mayerhofer K., Bodner-Adler B., Bodner K., Saletu B., Schindl M. & Kaider A. (2000) A paclitaxel-containing chemotherapy does not cause central nervous adverse effects: a prospective study with ovarian cancer. Anticancer Research 20, 4051-4055.
28. Mulsant B. & Ganguli M. (1999) Epidemiology and diagnosis of depression in late life. Journal of Clinical Psychiatry 60, 9-15.
29. Phillips K. & Bernhard J. (2003) Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. Journal of the National Cancer Institute 95, 190-197.
30. Rusiewicz A., DuHamel K.N., Burkhalter J., Ostroff J., Winkel G., Scigliano E., Papadopoulos E., Moskowitz C. & Redd W. (2008) Psychological distress in long-term survivors of hematopoietic stem cell transplantation. Psycho-oncology 17, 329-337.
31. Safilios-Rothchild C. (1982) Social and psychological parameters of friendship and intimacy for disabled people. In: Disabled People As Second Class Citizens (eds Eisenberg M., Griggens C. & Duvall R.), pp. 40-51. Springer, New York, USA.
32. Schagen S., Muller M., Boogerd W., Mellenbergh G. & Van Dam F. (2006) Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. Journal of the National Cancer Institute 98, 1742-1745.
33. Shilling V. & Jenkins V. (2007) Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. European Journal of Oncology Nursing 11, 6-15.
34. Stewart A., Bielajew C., Collins B., Parkinson M. & Tomiak E. (2006) A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clinical Neuropsychologist 20, 76-89.
35. Taillibert S., Voillery D. & Bernard-Marty C. (2007) Chemobrain: is systemic chemotherapy neurotoxic? Current Opinion in Oncology 19, 623-762.
36. Tannock I., Ahles T., Ganz P. & Van Dam F. (2004) Cognitive impairment associated with chemotherapy for cancer: report of a workshop. Journal of Clinical Oncology 22, 2233-2239.
37. Taylor B., Buckner J., Cascino T., O'Fallon J., Schaefer P., Dinapoli R.P. & Schomberg P. (1998) Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. Journal of Clinical Oncology 16, 2195-2201.
38. Valentine A. & Meyers C. (2001) Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer 92, 1694-1698.
39. Vardy J. & Tannock I. (2007) Cognitive function after chemotherapy in adults with solid tumours. Critical Reviews in Oncology/Hematology 63, 183-202.
40. Vardy J., Rourke S. & Tannock I. (2007) Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. Journal of Clinical Oncology 25, 2455-2463.
41. Verma P., Howard R. & Weiss B. (2008) The impact of race on outcomes of autologous transplantation in patients with multiple myeloma. American Journal of Hematology 83, 355-358.
42. Welzel G., Steinvorth S. & Wenz F. (2005) Cognitive effects of chemotherapy and/or cranial irradiation in adults. Strahlentherapie und Onkologie 181, 141-156.